Proposed issue of securities

Announcement Summary

For personal use only

Entity name

CRESO PHARMA LIMITED

Announcement Type

New announcement

Date of this announcement

17/1/2022

The Proposed issue is:

A placement or other type of issue

Total number of +securities proposed to be issued for a placement or other type of issue

Maximum Number of

ASX +security code

+Security description

+securities to be issued

New class-code to be

Options

10,000,000

confirmed

New class-code to be

Options

10,000,000

confirmed

New class-code to be

Performance Rights

7,500,000

confirmed

Proposed +issue date

24/3/2022

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 8

Proposed issue of securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of +Entity

CRESO PHARMA LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2

Registered Number Type

Registration Number

ABN

89609406911

1.3

ASX issuer code

CPH

  1. The announcement is New announcement
  2. Date of this announcement

17/1/2022

1.6 The Proposed issue is:

A placement or other type of issue

Proposed issue of securities

2 / 8

Proposed issue of securities

Part 7 - Details of proposed placement or other issue

only

Part 7A - Conditions

7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other

type of issue can proceed on an unconditional basis?

Yes

use

7A.1a Conditions

Approval/Condition

Date for determination

Is the date estimated or

** Approval

+Security holder approval

18/3/2022

actual?

received/condition met?

Estimated

No

Comments

The date of the above General Meeting is an estimate only. The Company will seek Shareholder approval for the issue of

personal

the securities the subject of this Appendix 3B at its next General Meeting.

Part 7B - Issue details

Is the proposed security a 'New

Will the proposed issue of this

class' (+securities in a class that is

+security include an offer of

not yet quoted or recorded by ASX)

attaching +securities?

or an 'Existing class' (additional

No

securities in a class that is already

quoted or recorded by ASX)?

New class

Details of +securities proposed to be issued

For

ISIN Code (if Issuer is a foreign company and +securities are non CDIs)

Have you received confirmation from

Will the entity be seeking quotation

ASX that the terms of the proposed

of the 'new' class of +securities on

+securities are appropriate and

ASX?

equitable under listing rule 6.1?

No

No

ASX +security code

+Security description

New class-code to be confirmed

Options

Proposed issue of securities

3 / 8

Proposed issue of securities

+Security type Options

Number of +securities proposed to be issued 10,000,000

only

Offer price details

Are the +securities proposed to be issued being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

To be issued to Mr Bruce Linton or his nominee, as an incentive based component to his remuneration package.

use

Please provide an estimate of the AUD equivalent of the consideration being

provided for the +securities

Will all the +securities issued in this class rank equally in all respects from

their issue date?

personal

Yes

proposed to be issued or provide the information by separate announcement.

Options details

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.0900

17/1/2024

Details of the type of +security that will be issued if the option is exercised

CPH : ORDINARY FULLY PAID

Number of securities that will be issued if the option is exercised

One Ordinary Share.

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities

For

Please note the material terms of these Options will be included in the Notice of Meeting for the Company's next General

Meeting, to be released on the ASX in due course.

Is the proposed security a 'New

Will the proposed issue of this

class' (+securities in a class that is

+security include an offer of

not yet quoted or recorded by ASX)

attaching +securities?

or an 'Existing class' (additional

No

securities in a class that is already

quoted or recorded by ASX)?

New class

Proposed issue of securities

4 / 8

Proposed issue of securities

Details of +securities proposed to be issued

ISIN Code (if Issuer is a foreign company and +securities are non CDIs)

only

Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1?

No

ASX +security code

New class-code to be confirmed

Will the entity be seeking quotation of the 'new' class of +securities on ASX?

No

+Security description

Options

personal use

+Security type

Options

Number of +securities proposed to be issued

10,000,000

Offer price details

Are the +securities proposed to be issued being issued for a cash consideration? No

Please describe the consideration being provided for the +securities

To be issued to Mr William Lay or his nominee, as an incentive based component to his remuneration package.

Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities

Will all the +securities issued in this class rank equally in all respects from their issue date?

Yes

Options details

For

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.2000

17/1/2024

Details of the type of +security that will be issued if the option is exercised

CPH : ORDINARY FULLY PAID

Number of securities that will be issued if the option is exercised

One Ordinary Shares.

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities

Proposed issue of securities

5 / 8

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Creso Pharma Ltd. published this content on 16 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 January 2022 23:04:04 UTC.